{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:09:40Z","timestamp":1793506180599,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Youth Foundation of China","doi-asserted-by":"crossref","award":["No. 81601604"],"award-info":[{"award-number":["No. 81601604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. BK20161070"],"award-info":[{"award-number":["No. BK20161070"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the talents program of Jiangsu Cancer Hospital","award":["No. YC201809"],"award-info":[{"award-number":["No. YC201809"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor recurrence and metastasis occur at a high rate in patients with colon cancer. Identification of effective strategies for the treatment of colon cancer is critical. Recently, poly (lactic-co-glycolic acid) (PLGA) has been shown to have potential as a broad therapeutic drug delivery system. We designed a dual-loaded nanoparticle drug delivery system to overcome the limitations of chemotherapeutic drugs used to treat colon cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed epidermal growth factor (EGF) functionalized PLGA nanoparticles (NPs) co-loaded with 5-fluorouracil (5Fu) and perfluorocarbon (PFC) (EGF-PLGA@5Fu\/PFC) for targeted treatment of colon cancer. CCK-8 assay, Hoechst33342 staining and flow cytometry were performed to investigate the functions of EGF-PLGA@5Fu\/PFC NPs in SW620 cells. Beside, animal experiment, histological analysis and immunofluorescence staining were adopted to further confirm the role of EGF-PLGA@5Fu\/PFC NPs in vivo\n                      <jats:italic>.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The findings showed that EGF-PLGA@5Fu \/PFC NPs had an average size 200\u2009nm and a 5Fu-loading efficiency of 7.29%. Furthermore, in vitro release was pH-sensitive. Targeted EGF-PLGA@5Fu\/PFC NPs exhibited higher cellular uptake than non-targeted NPs into colon cancer cells. In addition, EGF-PLGA@5Fu\/PFC NPs suppressed cell viability and induced apoptosis in SW620 cells to a greater extent than non-targeted NPs. In tumor xenografted mice, EGF-PLGA@5Fu\/PFC NPs suppressed tumor growth more effectively than 5Fu, PLGA@5Fu or PLGA@5Fu\/PFC NPs. Histopathological analysis further demonstrated that EGF-targeted NPs inhibited tumor growth to a greater extent than non-targeted or non-NP treatments. The improved therapeutic outcomes observed in this study were due to relief of tumor hypoxia by transport of oxygen by PFC to the tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We constructed a biocompatible nanodrug delivery system based on functionalized nanoparticles that provided a novel strategy for selective delivery of chemotherapy drugs to tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-06803-7","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T09:04:21Z","timestamp":1588064661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["RETRACTED ARTICLE: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon"],"prefix":"10.1186","volume":"20","author":[{"given":"Pingping","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"issue":"2","key":"6803_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"6803_CR2","first-page":"185","volume":"6","author":"P Yaffee","year":"2015","unstructured":"Yaffee P, Osipov A, Tan C, Tuli R, Hendifar A. Review of systemic therapies for locally advanced and metastatic rectal cancer. J Gastrointest Oncol. 2015;6(2):185\u2013200.","journal-title":"J Gastrointest Oncol"},{"key":"6803_CR3","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","author":"FU Din","year":"2017","unstructured":"Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 2017;12:7291\u2013309.","journal-title":"Int J Nanomedicine"},{"key":"6803_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.phrs.2017.05.004","volume":"126","author":"S Yang","year":"2017","unstructured":"Yang S, Gao H. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res. 2017;126:97\u2013108.","journal-title":"Pharmacol Res"},{"issue":"9","key":"6803_CR5","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1166\/jbn.2014.1884","volume":"10","author":"R Jeetah","year":"2014","unstructured":"Jeetah R, Bhaw-Luximon A, Jhurry D. Nanopharmaceutics: phytochemical-based controlled or sustained drug-delivery systems for cancer treatment. J Biomed Nanotechnol. 2014;10(9):1810\u201340.","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"6803_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biom9050196","volume":"9","author":"CIAV Santos","year":"2019","unstructured":"Santos CIAV, Ribeiro ACF, Esteso MA. Drug delivery systems: study of inclusion complex formation between Methylxanthines and Cyclodextrins and their Thermodynamic and Transport properties. Biomolecules. 2019;9(5):54.","journal-title":"Biomolecules"},{"issue":"9","key":"6803_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/molecules22091401","volume":"22","author":"L Palmerston Mendes","year":"2017","unstructured":"Palmerston Mendes L, Pan J, Torchilin VP. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. Molecules. 2017;22(9):1401.","journal-title":"Molecules"},{"issue":"8","key":"6803_CR8","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.nano.2017.08.005","volume":"13","author":"AG Grigoras","year":"2017","unstructured":"Grigoras AG. Polymer-lipid hybrid systems used as carriers for insulin delivery. Nanomedicine. 2017;13(8):2425\u201337.","journal-title":"Nanomedicine"},{"key":"6803_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","volume":"9","author":"S Rezvantalab","year":"2018","unstructured":"Rezvantalab S, Drude NI, Moraveji MK, G\u00fcvener N, Koons EK, Shi Y, et al. PLGA-based nanoparticles in Cancer treatment. Front Pharmacol. 2018;9:1260.","journal-title":"Front Pharmacol"},{"key":"6803_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2147\/IJN.S174962","volume":"14","author":"PC Lee","year":"2019","unstructured":"Lee PC, Zan BS, Chen LT, Chung TW. Multifunctional PLGA-based nanoparticles as a controlled release drug delivery system for antioxidant and anticoagulant therapy. Int J Nanomedicine. 2019;14:1533\u201349.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"6803_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/0885328219837683","volume":"33","author":"J Cai","year":"2019","unstructured":"Cai J, Qian K, Zuo X, Yue W, Bian Y, Yang J, et al. PLGA nanoparticle-based docetaxel\/LY294002 drug delivery system enhances antitumor activities against gastric cancer. J Biomater Appl. 2019;33(10):1394\u2013406.","journal-title":"J Biomater Appl"},{"issue":"17","key":"6803_CR12","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1021\/jf202135j","volume":"59","author":"X Xie","year":"2011","unstructured":"Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 2011;59(17):9280\u20139.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"6803_CR13","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.xphs.2018.10.042","volume":"108","author":"W Ni","year":"2019","unstructured":"Ni W, Li Z, Liu Z, Ji Y, Wu L, Sun S, et al. Dual-targeting nanoparticles: Codelivery of curcumin and 5-fluorouracil for synergistic treatment of Hepatocarcinoma. J Pharm Sci. 2019;108(3):1284\u201395.","journal-title":"J Pharm Sci"},{"key":"6803_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.colsurfb.2017.04.020","volume":"155","author":"A Sharma","year":"2017","unstructured":"Sharma A, Kaur A, Jain UK, Chandra R, Madan J. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells. Colloids Surf B Biointerfaces. 2017;155:200\u20138.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"43","key":"6803_CR15","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.1021\/acs.langmuir.7b03173","volume":"33","author":"P Astolfi","year":"2017","unstructured":"Astolfi P, Giorgini E, Gambini V, Rossi B, Vaccari L, Vita F, et al. Lyotropic liquid-crystalline Nanosystems as drug delivery agents for 5-fluorouracil: structure and cytotoxicity. Langmuir. 2017;33(43):12369\u201378.","journal-title":"Langmuir"},{"issue":"4","key":"6803_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40204-018-0104-3","volume":"7","author":"CG Hiremath","year":"2018","unstructured":"Hiremath CG, Kariduraganavar MY, Hiremath MB. Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting. Prog Biomater. 2018;7(4):297\u2013306.","journal-title":"Prog Biomater"},{"key":"6803_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.biopha.2018.09.128","volume":"108","author":"S Handali","year":"2018","unstructured":"Handali S, Moghimipour E, Rezaei M, Ramezani Z, Kouchak M, Amini M, et al. A novel 5-fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes. Biomed Pharmacother. 2018;108:1259\u201373.","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"6803_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijpharm.2017.02.006","volume":"521","author":"YA Haggag","year":"2017","unstructured":"Haggag YA, Matchett KB, Dakir EH, Buchanan P, Osman MA, Elgizawy SA, et al. Nano-encapsulation of a novel anti-ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells. Int J Pharm. 2017;521(1\u20132):40\u201353.","journal-title":"Int J Pharm"},{"issue":"6","key":"6803_CR19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3892\/ijmm.2017.2975","volume":"39","author":"K Li","year":"2017","unstructured":"Li K, Liu Y, Zhang S, Xu Y, Jiang J, Yin F, et al. Folate receptor-targeted ultrasonic PFOB nanoparticles: synthesis, characterization and application in tumor-targeted imaging. Int J Mol Med. 2017;39(6):1505\u201315.","journal-title":"Int J Mol Med"},{"issue":"3","key":"6803_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1423-0410.1991.tb00888.x","volume":"60","author":"KC Lowe","year":"1991","unstructured":"Lowe KC. Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology. Vox Sang. 1991;60(3):129\u201340.","journal-title":"Vox Sang"},{"issue":"2","key":"6803_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4155\/tde.10.13","volume":"1","author":"CM Hu","year":"2010","unstructured":"Hu CM, Aryal S, Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv. 2010;1(2):323\u201334.","journal-title":"Ther Deliv"},{"issue":"4","key":"6803_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4143\/crt.2017.487","volume":"50","author":"S Yun","year":"2018","unstructured":"Yun S, Kwak Y, Nam SK, Seo AN, Oh HK, Kim DW, et al. Ligand-independent epidermal growth factor receptor overexpression correlates with poor prognosis in colorectal Cancer. Cancer Res Treat. 2018;50(4):1351\u201361.","journal-title":"Cancer Res Treat"},{"issue":"42","key":"6803_CR23","doi-asserted-by":"publisher","first-page":"16365","DOI":"10.1039\/C7NR06898K","volume":"9","author":"H Jin","year":"2017","unstructured":"Jin H, Pi J, Zhao Y, Jiang J, Li T, Zeng X, et al. EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy. Nanoscale. 2017;9(42):16365\u201374.","journal-title":"Nanoscale"},{"issue":"11","key":"6803_CR24","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/molecules23112749","volume":"23","author":"\u00d6 Er","year":"2018","unstructured":"Er \u00d6, Colak SG, Ocakoglu K, Ince M, Bresol\u00ed-Obach R, Mora M, et al. Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine. Molecules. 2018;23(11):2749.","journal-title":"Molecules"},{"issue":"5","key":"6803_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1166\/jbn.2016.2231","volume":"12","author":"L Lv","year":"2016","unstructured":"Lv L, Qiu K, Yu X, Chen C, Qin F, Shi Y, et al. Amphiphilic Copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast Cancer. J Biomed Nanotechnol. 2016;12(5):973\u201385.","journal-title":"J Biomed Nanotechnol"},{"issue":"32","key":"6803_CR26","doi-asserted-by":"publisher","first-page":"26648","DOI":"10.1021\/acsami.7b05292","volume":"9","author":"Y Tang","year":"2017","unstructured":"Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, et al. Co-delivery of Trichosanthin and Albendazole by Nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces. 2017;9(32):26648\u201364.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6803_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-030-12734-3_9","volume":"1136","author":"LM Minassian","year":"2019","unstructured":"Minassian LM, Cotechini T, Huitema E, Graham CH. Hypoxia-induced resistance to chemotherapy in Cancer. Adv Exp Med Biol. 2019;1136:123\u201339.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"6803_CR28","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/mrm.25454","volume":"72","author":"ET Ahrens","year":"2014","unstructured":"Ahrens ET, Helfer BM, O\u2019Hanlon CF, Schirda C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med. 2014;72(6):1696\u2013701.","journal-title":"Magn Reson Med"},{"issue":"1","key":"6803_CR29","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41467-019-09389-2","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Cheng Y, Yu P, Wang H, Zhang Y, Xu H, et al. Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy. Nat Commun. 2019;10(1):1580.","journal-title":"Nat Commun"},{"issue":"2","key":"6803_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7150\/ntno.29908","volume":"3","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Bernards N, Hoang B, Zheng J, Matsuura N. Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing. Nanotheranostics. 2019;3(2):135\u201344.","journal-title":"Nanotheranostics"}],"updated-by":[{"DOI":"10.1186\/s12885-026-16805-6","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06803-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-06803-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06803-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:41:12Z","timestamp":1787398872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-020-06803-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["6803"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06803-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17524\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17524\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17524\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17524\/v4","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-026-16805-6","URL":"https:\/\/doi.org\/10.1186\/s12885-026-16805-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the methodologies in animal experiment were conducted in accordance with the Guidelines for Care and Use of Laboratory Animals of the University of Science and Technology of China. This work was approved by the Animal Ethics Committee of Nanjing Medical University.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"354"}}